Applied DNA Sciences, Inc. (APDN)

Market Cap	2.75M
Revenue (ttm)	3.79M
Net Income (ttm)	-46.19M
Shares Out	520.00K
EPS (ttm)	-944.52
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	99,158
Open	4.74
Previous Close	4.73
Day's Range	4.74 - 5.50
52-Week Range	4.37 - 2,655.00
Beta	0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2025

About APDN

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-base...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1983
• Employees: 48
• Stock Exchange: NASDAQ
• Ticker Symbol: APDN
• Website: https://www.adnas.com

Financial Performance

In 2024, Applied DNA Sciences's revenue was $3.43 million, a decrease of -74.33% compared to the previous year's $13.37 million. Losses were -$7.23 million, -27.36% less than in 2023.